EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of human basophil and lung mast cell function by cyclic amp






Journal of Immunology 140(2): 571-579

Regulation of human basophil and lung mast cell function by cyclic amp

Immunologic activation of purified human lung mast cells (HLMC) and basophils with anti-IgE induced histamine release but failed to elicit any changes in cAMP levels. In contrast, histamine release and monophasic rises in cAMP were observed in both rat peritoneal mast cells (RPMC) challenged with concanavalin A (73% enhancement over basal cAMP 20 sec after activation) and a cultured mouse the bone marrow-derived mast cell (PT18 cell line) passively sensitized with dinitrophenol-specific IgE and stimulated with antigen (39% increase above basal at 15 sec). The adenylate cyclase activators isoprenaline, prostaglandin E2 (PGE2), and forskolin and the phosphodiesterase inhibitor isobuylmethylxanthine (IBMX) all induced elevations in cAMP levels in both basophils and HLMC. In basophils, PGE2 and isoprenaline produced approximately twofold increases in cAMP that were maximal at 1 min and decayed thereafter. Forskolin and IBMX produced threefold increases in cAMP that peaked 10 min after activation and persisted for up to 20 min. In HLMC, isoprenaline provoked a rapid monophasic fourfold increase in cAMP that was maximal at 1 min after addition. Levels of cAMP subsequently declined but remained significantly elevated over resting levels for up to 30 min. PGE2, forskolin, and IBMX all produced approximately threefold rises in HLMC cAMP that peaked around 5 min and persisted for 30 min. In both the basophil and HLMC, agonist-induced elevations in cAMP correlated well with the inhibition of mediator release. In basophils, the order IBMX > forskolin > PGE2 > isoprenaline held for both the inhibition of histamine and leukotriene C4 release and the augmentation of cAMP levels. In HLMC, individual agonists elevated cAMP levels to similar degrees and inhibited the release of histamine, leukotriene C4, and PGD2 to comparable extents, although the release of the arachidonate metabolites was generally more sensitive to the inhibitory actions of these agonists. These results suggest that elevations in cAMP, in both the basophil and HLMC, are associated with the inhibition of mediator release but not the initiation of the secretory process.


Accession: 006288513



Related references

Peachell P.; Macglashan D.; Lichtenstein L.; Schleimer R., 1987: Regulation of human lung mast cell and basophil function by cyclic amp. Federation Proceedings 46(3): 1029

Peachell, P.T.; MacGlashan, D.W.; Lichtenstein, L.M.; Schleimer, R.P., 1988: Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. Immunologic activation of purified human lung mast cells (HLMC) and basophils with anti-IgE induced histamine release but failed to elicit any changes in cAMP levels. In contrast, histamine release and monophasic rises in cAMP were observed in bot...

Peachell, P.T.; Lichtenstein, L.M.; Schleimer, R.P., 1991: Differential regulation of human basophil and lung mast cell function by adenosine. Adenosine was found to modulate the activity of the human basophil and lung mast cell (HLMC) differently. In the basophil, adenosine inhibited the anti-IgE stimulated release of histamine and leukotriene C4 (LTC4) and increased total cell cyclic A...

Ali, H., 2010: Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Allergic diseases such as asthma result from inappropriate immunologic responses to common environmental allergens in genetically susceptible individuals. Following allergen exposure, interaction of dendritic cells (DC) with CD4(+) T cells leads t...

Weston, M.C.; Peachell, P.T., 1998: Regulation of human mast cell and basophil function by cAMP. 1. Mast cells and basophils are important in mediating allergic disorders such as asthma. Activation of these cells results in the release of a wide variety of mediators that can promote inflammatory responses. 2. Receptor-mediated activators of a...

Peirce, M.J.; Munday, M.R.; Peachell, P.T., 1999: Role of protein phosphatases in the regulation of human mast cell and basophil function. Many extracellular stimuli mediate physiological change in target cells by altering the phosphorylation state of proteins. These alterations result from the dynamic interplay of protein kinases, which mediate phosphorylations, and protein phosphat...

Schulman E.S.; Post T.J.; Vigderman R.J., 1984: Effects of t cell growth factor on human basophil and lung mast cell histamine release. Journal of Allergy & Clinical Immunology 73(1 PART 2): 120

Peachell, P.T.; Munday, M.R., 1993: Regulation of human lung mast cell function by phosphatase inhibitors. Okadaic acid, a cell-permeant inhibitor of serine/threonine phosphatases (PP) was found to attenuate the IgE-mediated release of both performed (histamine) and newly formed (leukotriene C4) mediators from human lung mast cells (HLMC). Optimal inhi...

Schulman E.S.; Matsushima K.; Raible D.; Grover N.; Post T., 1990: Differential effects of interleukin 8 on human basophil and human lung mast cell histamine release. Clinical Research 38(2): 249A

Rich, K.L.; Priest, R.; Warner, J.A., 1999: The role of L-selectin ligation in human mast cell and basophil function. Journal of Allergy & Clinical Immunology 103(1 PART 2): S209, Jan